Janone Inc. (NASDAQ:ALTS) Short Interest Down 37.7% in September

Janone Inc. (NASDAQ:ALTS) was the recipient of a large decrease in short interest in the month of September. As of September 30th, there was short interest totalling 221,000 shares, a decrease of 37.7% from the September 15th total of 355,000 shares. Based on an average daily volume of 290,700 shares, the short-interest ratio is presently 0.8 days. Currently, 1.9% of the company’s stock are short sold.

Janone Stock Up 3.4 %

Shares of NASDAQ ALTS opened at $1.81 on Monday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. Janone has a 1-year low of $0.29 and a 1-year high of $5.26. The business has a fifty day moving average of $2.03.

Janone Company Profile

JanOne Inc, a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology.